Filing Details

Accession Number:
0001209191-13-007870
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-02-11 19:19:06
Reporting Period:
2013-02-11
Filing Date:
2013-02-11
Accepted Time:
2013-02-11 19:19:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
949699 Pharmacyclics Inc PCYC Pharmaceutical Preparations (2834) 943148201
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1412679 J Joseph Buggy C/O Pharmacyclics, Inc.
995 East Arques Avenue
Sunnyvale CA 94085-4521
Vp, Research No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-02-11 12,000 $0.86 18,701 No 4 M Direct
Common Stock Disposition 2013-02-11 12,000 $69.97 6,701 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2013-02-11 12,000 $0.00 12,000 $0.86
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
81,313 2008-03-18 2018-03-18 No 4 M Direct
Footnotes
  1. Sale of shares pursuant to Rule 10b5-1 Plan adopted on January 10, 2013.
  2. The shares subject to the option will vest as follows: 25% of the shares subject to the option will vest on March 18, 2009 and 1/36th of the remaining shares will vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on March 18, 2012, subject to the Reporting Person's continued employment or service relationship with the Issuer on each of the vesting dates.